(Q38844891)

6 September 2017

title

Syndecan-1 up-regulates microRNA-331-3p and mediates epithelial-to-mesenchymal transition in prostate cancer (English)

1 reference

6 September 2017

1 reference

1 reference

Tomomi Fujii

1

1 reference

6 September 2017

Keiji Shimada

2

1 reference

6 September 2017

Yoshihiro Tatsumi

3

1 reference

6 September 2017

Nobumichi Tanaka

4

1 reference

6 September 2017

Kiyohide Fujimoto

5

1 reference

6 September 2017

Noboru Konishi

6

1 reference

6 September 2017

publication date

10 August 2015

1 reference

6 September 2017

published in

Molecular Carcinogenesis

1 reference

6 September 2017

volume

55

1 reference

6 September 2017

issue

9

1 reference

6 September 2017

page(s)

1378-1386

1 reference

Functions of cell surface heparan sulfate proteoglycans

6 September 2017

cites work

1 reference

Role of syndecan-1 (CD138) in cell survival of human urothelial carcinoma.

21 January 2018

1 reference

Automated analysis of immunohistochemistry images identifies candidate location biomarkers for cancers

21 January 2018

1 reference

CCL2 Chemokine as a Potential Biomarker for Prostate Cancer: A Pilot Study

21 January 2018

1 reference

Active surveillance in patients with a PSA >10 ng/mL.

21 January 2018

1 reference

Prognostic DNA methylation markers for prostate cancer.

21 January 2018

1 reference

High expression of a new marker PCA-1 in human prostate carcinoma

21 January 2018

1 reference

MicroRNA expression and function in cancer

21 January 2018

1 reference

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

Prediction of mammalian microRNA targets

21 January 2018

1 reference

Causes and consequences of microRNA dysregulation in cancer

21 January 2018

1 reference

21 January 2018

1 reference

MicroRNA functions in animal development and human disease

21 January 2018

1 reference

Preferential star strand biogenesis of pre-miR-24-2 targets PKC-alpha and suppresses cell survival in MCF-7 breast cancer cells

21 January 2018

1 reference

MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines.

21 January 2018

1 reference

MicroRNA-191, by promoting the EMT and increasing CSC-like properties, is involved in neoplastic and metastatic properties of transformed human bronchial epithelial cells

21 January 2018

1 reference

Polyamines are oncometabolites that regulate the LIN28/let-7 pathway in colorectal cancer cells

21 January 2018

1 reference

MiR-96-5p influences cellular growth and is associated with poor survival in colorectal cancer patients.

21 January 2018

1 reference

Post-transcriptional up-regulation of miR-21 by type I collagen

21 January 2018

1 reference

Syndecan-1, a new target molecule involved in progression of androgen-independent prostate cancer

21 January 2018

1 reference

Syndecan-1 (CD138) contributes to prostate cancer progression by stabilizing tumour-initiating cells

21 January 2018

1 reference

Syndecan-1 responsive microRNA-126 and 149 regulate cell proliferation in prostate cancer

21 January 2018

1 reference

MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms

21 January 2018

1 reference

BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition.

21 January 2018

1 reference

Identification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMT

21 January 2018

1 reference

miR-154 inhibits EMT by targeting HMGA2 in prostate cancer cells

21 January 2018

1 reference

MiR-182 and miR-203 induce mesenchymal to epithelial transition and self-sufficiency of growth signals via repressing SNAI2 in prostate cells

21 January 2018

1 reference

miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells

21 January 2018

1 reference

Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer

21 January 2018

1 reference

Regulatory networks defining EMT during cancer initiation and progression

21 January 2018

1 reference

Regulation of EMT by TGFβ in cancer.

21 January 2018

1 reference

Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer

21 January 2018

1 reference

miR-331-3p regulates expression of neuropilin-2 in glioblastoma

21 January 2018

1 reference

The RNA-binding protein HuR opposes the repression of ERBB-2 gene expression by microRNA miR-331-3p in prostate cancer cells

21 January 2018

1 reference

MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase

21 January 2018

1 reference

Enhancing integrin function by VEGF/neuropilin signaling: implications for tumor biology

21 January 2018

1 reference

A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival

21 January 2018

1 reference

Low expression of nucleus accumbens-associated protein 1 predicts poor prognosis for patients with pancreatic ductal adenocarcinoma

21 January 2018

1 reference

Dicer expression and microRNA dysregulation associate with aggressive features in thyroid cancer

21 January 2018

1 reference

Prognostic significance of deregulated dicer expression in breast cancer

21 January 2018

1 reference

Down-regulation of Dicer and Ago2 is associated with cell proliferation and apoptosis in prostate cancer.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MC.22381

1 reference

6 September 2017

1 reference